Patti Katz, PhD

Professor

Honors and Awards
  • Rheumatology Research Foundation, Ambassador, 2019-curr
  • Excellence in Investigative Mentoring, American College of Rheumatology, 2019
  • Co-Editor-in-Chief, ACR Open Rheumatology, 2018-curr
  • Deputy Editor for Methodology and Biostatistics, Journal of Bone and Joint Surgery, 2018-curr
  • Lifetime Achievement Award, Association of Rheumatology Health Professionals/American College of Rheumatology, 2015
  • President's Award, Association of Rheumatology Health Professionals/American College of Rheumatology, 2010
  • Outstanding Orthopaedic Clinical Research Award, Orthopaedic Research and Education Foundation, 2006
  • Co-Editor-in-Chief, Arthritis Care & Research, 2005-2011
  • Guest editor, Special issue, Outcomes in Rheumatology: A review of Measures, Arthritis Care & Research, 2003
  • President's Award, Association of Rheumatology Health Professionals/American College of Rheumatology, 2003
  • Award of Special Recognition, California Arthritis Foundation Council, 1998
  • Guest Editor, Special Issue on Outcomes, Arthritis Care & Research, 1997
  • Distinguished Scholar, Association of Rheumatology Health Professionals/American College of Rheumatology, 1997
  • Associate Editor, Arthritis Care & Research, 1994-2005
Websites
Publications
  1. Patient-reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic.
  2. Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression.
  3. Major Depression and Adverse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Results from the California Lupus Epidemiology Study.
  4. The impact of limited health literacy on patient-reported outcomes in systemic lupus erythematosus.
  5. Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus.
  6. Cognitive function trajectories are associated with the depressive symptoms trajectories in systemic lupus erythematosus over time.
  7. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
  8. Sex differences in frailty and its association with low bone mineral density in rheumatoid arthritis.
  9. Quality of Care for the Screening, Diagnosis, and Management of Lupus Nephritis Across Multiple Healthcare Settings.
  10. Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient-Reported Outcomes Measurement Information System Pain Interference Short Form in Rheumatoid Arthritis.
  11. Experiences of Patients with Rheumatic Diseases in the US During Early Days of the COVID-19 Pandemic.
  12. Frailty after lung transplantation is associated with impaired health-related quality of life and mortality.
  13. Benefits and promotion of physical activity in rheumatoid arthritis.
  14. Patient and clinician perspectives on a patient-facing dashboard that visualizes patient reported outcomes in rheumatoid arthritis.
  15. Relationships Between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus.
  16. Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
  17. Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus.
  18. Defining Pain That Does Not Interfere With Activities Among Rheumatoid Arthritis (RA) Patients.
  19. Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus.
  20. Psychometric evaluation of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS® ) in a multi-racial, multi-ethnic systemic lupus erythematosus (SLE) cohort.
  21. The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study.
  22. A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus.
  23. Longitudinal Study of Fatigue, Stress, and Depression: Role of Reduction in Stress Towards Improvement in Fatigue.
  24. The Impact of Frailty on Changes in Physical Function and Disease Activity Among Adults With Rheumatoid Arthritis.
  25. Patient Reported Outcomes Predict Mortality in Lupus.
  26. Effects of language, insurance and race/ethnicity on measurement properties of the PROMIS Physical Function Short Form 10a in rheumatoid arthritis.
  27. Frailty trajectories in adult lung transplantation: A cohort study.
  28. Opening Salvo.
  29. The Association Between Yoga Use, Physical Function, and Employment in Adults With Rheumatoid Arthritis.
  30. Obesity Independently Associates with Worse Patient-Reported Outcomes in Women with Systemic Lupus Erythematosus.
  31. The Assessment of Anxiety and Depression and its Associated Factors in SLE.
  32. Symptoms of Anxiety and Depression Among Adults with Arthritis - United States, 2015-2017.
  33. Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.
  34. Patient-reported outcome measures for use in clinical trials of SLE: a review.
  35. Frailty phenotypes and mortality after lung transplantation: A prospective cohort study.
  36. Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis.
  37. Depression Risk in Young Adults With Juvenile- and Adult-Onset Lupus: Twelve Years of Followup.
  38. Cognitive Impairment in Rheumatoid Arthritis: A Systematic Review.
  39. Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.
  40. Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus.
  41. Physical Activity to Reduce Fatigue in Rheumatoid Arthritis: A Randomized Controlled Trial.
  42. Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.
  43. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.
  44. Performance of the Patient-Reported Outcomes Measurement Information System 29-Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus.
  45. Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical Illness.
  46. Systemic lupus erythematosus: The promise of PROMIS - is it ready for prime time in SLE?
  47. Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis.
  48. Causes and consequences of fatigue in rheumatoid arthritis.
  49. Fatigue in Rheumatoid Arthritis.
  50. Reply.
  51. Validity and Responsiveness of a 10-Item Patient-Reported Measure of Physical Function in a Rheumatoid Arthritis Clinic Population.
  52. Association of Slow Gait Speed With Trajectories of Worsening Depressive Symptoms in Knee Osteoarthritis: An Observational Study.
  53. Is frailty a relevant concept in SLE?
  54. Frailty and reduced physical function go hand in hand in adults with rheumatoid arthritis: a US observational cohort study.
  55. A Qualitative Study Exploring Community Yoga Practice in Adults with Rheumatoid Arthritis.
  56. Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study.
  57. Serum biomarkers of inflammation and muscle strength among women with systemic lupus erythematosus.
  58. Exercise as Medicine.
  59. Link Between Foot Pain Severity and Prevalence of Depressive Symptoms.
  60. The Sexual Impact of Infertility Among Women Seeking Fertility Care.
  61. Poverty, Depression, or Lost in Translation? Ethnic and Language Variation in Patient-Reported Outcomes in Rheumatoid Arthritis.
  62. The Patient Experience: Patient-Reported Outcomes in Rheumatology.
  63. Addressing the needs of fertility treatment patients and their partners: are they informed of and do they receive mental health services?
  64. National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia.
  65. Role of Sleep Disturbance, Depression, Obesity, and Physical Inactivity in Fatigue in Rheumatoid Arthritis.
  66. Obesity and Functioning Among Individuals with Chronic Obstructive Pulmonary Disease (COPD).
  67. Foot Pain and Pronated Foot Type Are Associated with Self-Reported Mobility Limitations in Older Adults: The Framingham Foot Study.
  68. Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.
  69. Validation and internal consistency of the Swedish version of the Valued Life Activities scale.
  70. Leg Muscle Mass and Foot Symptoms, Structure, and Function: The Johnston County Osteoarthritis Project.
  71. Muscle Strength and Changes in Physical Function in Women With Systemic Lupus Erythematosus.
  72. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis.
  73. Interactions between patients, providers, and health systems and technical quality of care.
  74. Are men at greater risk of lean mass deficits in rheumatoid arthritis?
  75. Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus.
  76. Defining novel health-related quality of life domains in lung transplantation: a qualitative analysis.
  77. The associations of leg lean mass with foot pain, posture and function in the Framingham foot study.
  78. Body composition and mortality after adult lung transplantation in the United States.
  79. English language proficiency, health literacy, and trust in physician are associated with shared decision making in rheumatoid arthritis.
  80. Longitudinal validation of the Brief Index of Lupus Damage.
  81. Temporal and geospatial trends in male factor infertility with assisted reproductive technology in the United States from 1999-2010.
  82. Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.
  83. Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study.
  84. Annual average ambient particulate matter exposure estimates, measured home particulate matter, and hair nicotine are associated with respiratory outcomes in adults with asthma.
  85. Development and validation of a lung transplant-specific disability questionnaire.
  86. Responding to clinicians who fail to follow patient safety practices: perceptions of physicians, nurses, trainees, and patients.
  87. Out-of-pocket fertility patient expense: data from a multicenter prospective infertility cohort.
  88. Reply: To PMID 22505279.
  89. Missed opportunities for depression screening in patients with arthritis in the United States.
  90. Foot pain and mobility limitations in older adults: the Framingham Foot Study.
  91. Relationship between perceived cognitive dysfunction and objective neuropsychological performance in persons with rheumatoid arthritis.
  92. Time costs of fertility care: the hidden hardship of building a family.
  93. Higher environmental relative moldiness index values measured in homes of adults with asthma, rhinitis, or both conditions.
  94. The relationship between cognitive function and physical function in rheumatoid arthritis.
  95. Sex differences in assessment of obesity in rheumatoid arthritis.
  96. Mediators of the socioeconomic gradient in outcomes of adult asthma and rhinitis.
  97. The role of social support in anxiety for persons with COPD.
  98. Assessment of health-related family role functioning in systemic lupus erythematosus: preliminary validation of a new measure.
  99. Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.
  100. Lower health literacy is associated with poorer health status and outcomes in chronic obstructive pulmonary disease.
  101. Cognitive impairment in persons with rheumatoid arthritis.
  102. Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease.
  103. Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD.
  104. Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care.
  105. Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus.
  106. Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer.
  107. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes.
  108. Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus.
  109. Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus.
  110. Fertility treatment response: is it better to be more optimistic or less pessimistic?
  111. Development and validation of a short form of the valued life activities disability questionnaire for rheumatoid arthritis.
  112. Introduction to special issue: patient outcomes in rheumatology, 2011.
  113. Impact of obesity on functioning among women with systemic lupus erythematosus.
  114. Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up.
  115. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer.
  116. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer.
  117. Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.
  118. Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus.
  119. Socioeconomic disparities in the use and success of fertility treatments: analysis of data from a prospective cohort in the United States.
  120. The role of physical inactivity in increasing disability among older adults with obstructive airway disease.
  121. Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus.
  122. Introduction to special theme: vascular comorbidity in the rheumatic diseases.
  123. Long-term patterns of depression and associations with health and function in a panel study of rheumatoid arthritis.
  124. Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function.
  125. Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus.
  126. Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis.
  127. Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension.
  128. Evaluating quality of life in patients with asthma and rhinitis: English adaptation of the rhinasthma questionnaire.
  129. Depression in patients with rheumatoid arthritis: description, causes and mechanisms.
  130. Introduction to special section: quality of care in the rheumatic diseases.
  131. Costs of infertility treatment: results from an 18-month prospective cohort study.
  132. Development of disability in chronic obstructive pulmonary disease: beyond lung function.
  133. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy.
  134. Onset of depressive symptoms among adults with asthma: results from a longitudinal observational cohort.
  135. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus.
  136. Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States.
  137. Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus.
  138. An integrated model of environmental factors in adult asthma lung function and disease severity: a cross-sectional study.
  139. Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective U.S. cohort.
  140. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study.
  141. The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States.
  142. Disability in valued life activities among individuals with COPD and other respiratory conditions.
  143. Frequent use of the emergency department among persons with systemic lupus erythematosus.
  144. Influence of anxiety on health outcomes in COPD.
  145. Clinical trial registration and publication of randomized controlled trials.
  146. Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort.
  147. Screening for depression in chronic obstructive pulmonary disease.
  148. The child, grown, becomes independent.
  149. The impact of disability on depression among individuals with COPD.
  150. Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis.
  151. Socioeconomic status, race and COPD health outcomes.
  152. The COPD Helplessness Index: a new tool to measure factors affecting patient self-management.
  153. Introduction to special section: epidemiology of the rheumatic diseases.
  154. Impact of duty-hour restriction on resident inpatient teaching.
  155. Depression and health-related quality of life in chronic obstructive pulmonary disease.
  156. Sexual, marital, and social impact of a man's perceived infertility diagnosis.
  157. Further exploration of the links between occupational exposure and chronic obstructive pulmonary disease.
  158. Perceived negative consequences of donor gametes from male and female members of infertile couples.
  159. Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade.
  160. Patient-reported outcomes following biologic therapy in a sample of adults with rheumatoid arthritis recruited from community-based rheumatologists.
  161. The impact of SHS exposure on health status and exacerbations among patients with COPD.
  162. Depression, medication adherence, and service utilization in systemic lupus erythematosus.
  163. Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample.
  164. Exposure to traffic: lung function and health status in adults with asthma.
  165. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.
  166. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus.
  167. The COPD severity score: a dynamic prediction tool for health-care utilization.
  168. Subclinical disability in valued life activities among individuals with rheumatoid arthritis.
  169. Patterns of psychosocial risk and long-term outcomes in rheumatoid arthritis.
  170. Factors associated with intern fatigue.
  171. Performance of self-reported occupational exposure compared to a job-exposure matrix approach in asthma and chronic rhinitis.
  172. COPD as a systemic disease: impact on physical functional limitations.
  173. Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions.
  174. Occupational exposures and the risk of COPD: dusty trades revisited.
  175. Risk factors for death in adults with severe asthma.
  176. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus.
  177. Disability in valued life activities among individuals with systemic lupus erythematosus.
  178. Introduction to special section: cost and social and psychological impact of rheumatic diseases.
  179. Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease.
  180. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.
  181. Socioeconomic gradients in tiotropium use among adults with COPD.
  182. Impact of memory impairment on employment status in persons with systemic lupus erythematosus.
  183. Impact of perceived neighborhood problems on change in asthma-related health outcomes between baseline and follow-up.
  184. Use of accommodations for valued life activities: prevalence and effects on disability scores.
  185. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus.
  186. Medicaid and access to care among persons with systemic lupus erythematosus.
  187. Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus.
  188. Contributions of OMERACT to rheumatic disease research.
  189. Work dynamics among persons with systemic lupus erythematosus.
  190. Racial/ethnic differences in the use of complementary and alternative medicine in patients with arthritis.
  191. The impact of duty hours on resident self reports of errors.
  192. Body composition and functional limitation in COPD.
  193. The influence of perceived control of asthma on health outcomes.
  194. Risk factors for work disability in severe adult asthma.
  195. Time use patterns among women with rheumatoid arthritis: association with functional limitations and psychological status.
  196. Negative life events and quality of life in adults with asthma.
  197. Development of classification and response criteria for rheumatic diseases.
  198. Journal policies on authorship and disclosures.
  199. Directly measured secondhand smoke exposure and COPD health outcomes.
  200. Journal policies on authorship and disclosures.
  201. Measuring disease-specific quality of life in obstructive airway disease: validation of a modified version of the airways questionnaire 20.
  202. Childbearing decisions and family size among women with rheumatoid arthritis.
  203. Perceived neighborhood problems and quality of life, physical functioning, and depressive symptoms among adults with asthma.
  204. Work life of persons with asthma, rhinitis, and COPD: a study using a national, population-based sample.
  205. Area-level socio-economic status and health status among adults with asthma and rhinitis.
  206. Impact of reduced duty hours on residents' educational satisfaction at the University of California, San Francisco.
  207. Use of self-management behaviors to cope with rheumatoid arthritis stressors.
  208. Evaluating change in health-related quality of life in adult rhinitis: responsiveness of the Rhinosinusitis Disability Index.
  209. Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment.
  210. Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis.
  211. Functioning and psychological status among individuals with COPD.
  212. Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix.
  213. New journal policy regarding registration of clinical trials.
  214. Impact of managed care on the use of biologic agents for rheumatoid arthritis.
  215. Development and validation of a survey-based COPD severity score.
  216. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease.
  217. Impact of depressive symptoms on adult asthma outcomes.
  218. Impact of exogenous glucocorticoid use on salivary cortisol measurements among adults with asthma and rhinitis.
  219. Impact of the home indoor environment on adult asthma and rhinitis.
  220. Hospital resource utilization for primary and revision total hip arthroplasty.
  221. Health-related quality of life in adult rhinitis: the role of perceived control of disease.
  222. Impact of social support on valued activity disability and depressive symptoms in patients with rheumatoid arthritis.
  223. The association between occupational factors and adverse health outcomes in chronic obstructive pulmonary disease.
  224. The impact of managed care on health care utilization among adults with asthma.
  225. Leukotriene modifier use and asthma severity: how is a new medication being used by adults with asthma?
  226. Performance of valued life activities reflected asthma-specific quality of life more than general physical function.
  227. Function, disability, and psychological well-being.
  228. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis.
  229. The occupational burden of chronic obstructive pulmonary disease.
  230. A comprehensive study of the direct and indirect costs of adult asthma.
  231. Effect of valued activity disability, social comparisons, and satisfaction with ability on depressive symptoms in rheumatoid arthritis.
  232. Effects of physician-related factors on adult asthma care, health status, and quality of life.
  233. Development of an instrument to measure disability in parenting activity among women with rheumatoid arthritis.
  234. Implementation of a voluntary hospitalist service at a community teaching hospital: improved clinical efficiency and patient outcomes.
  235. Exposure to indoor combustion and adult asthma outcomes: environmental tobacco smoke, gas stoves, and woodsmoke.
  236. The economic impact of the assisted reproductive technologies.
  237. Perceived control of asthma and quality of life among adults with asthma.
  238. Focusing interventions for disability among patients with rheumatoid arthritis.
  239. Author perception of peer review: impact of review quality and acceptance on satisfaction.
  240. The prevalence and impact of managed care for persons with rheumatoid arthritis in 1994 and 1999.
  241. Primary care physician attitudes regarding communication with hospitalists.
  242. A national study of medical care expenditures for respiratory conditions.
  243. Primary care physician attitudes regarding communication with hospitalists.
  244. A pneumonia practice guideline and a hospitalist-based reorganization lead to equivalent efficiency gains.
  245. Alternative therapies among adults with a reported diagnosis of asthma or rhinosinusitis : data from a population-based survey.
  246. Measurement of environmental tobacco smoke exposure among adults with asthma.
  247. Does satisfaction with abilities mediate the relationship between the impact of rheumatoid arthritis on valued activities and depressive symptoms?
  248. The work impact of asthma and rhinitis: findings from a population-based survey.
  249. Activity loss and the onset of depressive symptoms: do some activities matter more than others?
  250. Acknowledgement and corrections for flawed data.
  251. Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity.
  252. Physician attitudes toward and prevalence of the hospitalist model of care: results of a national survey.
  253. Retraction.
  254. Predictors of cigarette smoking and smoking cessation among adults with asthma.
  255. Reanalysis of Blanc PD et al, "Use of herbal products, coffee or black tea, and over-the-counter medications as self treatments among adults with asthma".
  256. Health insurance characteristics and health care evaluations among persons with rheumatic diseases in California.
  257. The Marks Asthma Quality of Life Questionnaire: further validation and examination of responsiveness to change.
  258. Work dynamics of adults with asthma.
  259. Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group.
  260. Evaluating the impact of hospitalists.
  261. Hospitalists and the practice of inpatient medicine: results of a survey of the National Association of Inpatient Physicians.
  262. Methods to estimate and analyze medical care resource use. An example from liver transplantation.
  263. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma.
  264. Assessment of asthma severity in adults with asthma treated by family practitioners, allergists, and pulmonologists.
  265. Reorganizing an academic medical service: impact on cost, quality, patient satisfaction, and education.
  266. Education and self-care activities among persons with rheumatoid arthritis.
  267. The stresses of rheumatoid arthritis: appraisals of perceived impact and coping efficacy.
  268. Choosing quality and outcomes measures for rheumatic diseases.
  269. Outcomes research: an overview.
  270. Pulmonary and allergy subspecialty care in adults with asthma. Treatment, use of services, and health outcomes.
  271. Use of herbal products, coffee or black tea, and over-the-counter medications as self-treatments among adults with asthma.
  272. Satisfaction with abilities and well-being: development and validation of a questionnaire for use among persons with rheumatoid arthritis.
  273. Perceived control of asthma: development and validation of a questionnaire.
  274. The relationship between fibromyalgia and interstitial cystitis.
  275. Differences in symptom reports between men and women with rheumatoid arthritis.
  276. Health service use among low-risk newborns after early discharge with and without nurse home visiting.
  277. The impact of rheumatoid arthritis on life activities.
  278. The development of depressive symptoms among women with rheumatoid arthritis. The role of function.
  279. Relationship of education level to treatment received for rheumatoid arthritis.
  280. Mortality risk among elderly workers.
  281. Life activities of persons with rheumatoid arthritis with and without depressive symptoms.
  282. Approach to the patient with rheumatoid arthritis.
  283. Making work more central to work disability policy.
  284. Work disability among adults with asthma.
  285. Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis.
  286. Ectopic pregnancy in the United States: economic consequences and payment source trends.
  287. Use of cyclosporin A in the eosinophilia myalgia syndrome.
  288. Serum cytokines and the eosinophilia myalgia syndrome.
  289. Dyspnea and pulmonary function in the L-tryptophan-associated eosinophilia-myalgia syndrome.
  290. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000.
  291. Labor force participation among persons with musculoskeletal conditions, 1970-1987. National estimates derived from a series of cross-sections.
  292. No firm basis to advocate auranofin in the treatment of juvenile rheumatoid arthritis.
  293. Epidemiology and prevention of periodontal disease in individuals with diabetes.
  294. Effect of parenterally administered gold therapy on the course of adult rheumatoid arthritis.
  295. Risk factors for hospital malpractice exposure: implications for managers and insurers.
  296. The association of cyclosporine with the 1-year costs of cadaver-donor kidney transplants.
  297. Is it worth it? Evaluating the economic impact of worksite health promotion.
  298. Transitions in health status among community-dwelling elderly people with arthritis. A national, longitudinal study.
  299. The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control.
  300. Tryptophan-associated eosinophilic connective-tissue disease. A new clinical entity?
  301. Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes.
  302. The effect of cyclosporine on the use of hospital resources for kidney transplantation.
  303. Therapeutic strategies in autoimmune disease: cyclosporin A as a model agent.
  304. Rheumatoid vasculitis: experience with 13 patients and review of the literature.
  305. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.